keyword
https://read.qxmd.com/read/37418329/drugs-for-inflammatory-bowel-disease
#1
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
July 10, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36874321/lupus-cardiomyopathy-and-nephritis-associated-with-adalimumab-and-cytomegalovirus-infection-in-a-patient-with-seronegative-rheumatoid-arthritis-a-case-of-rhupus-syndrome
#2
Palapun Waitayangkoon, Lucas Chen, Jessica B Liu, Astrid Weins, Felipe Barbosa, Thomas Treadwell
Tumor necrosis factor-alpha (TNF-α) inhibitors are associated with lupus-like disease, known as anti-TNF-α-induced lupus (ATIL). Cytomegalovirus (CMV) was reported to exacerbate lupus in the literature. To date, systemic lupus erythematosus (SLE) triggered by adalimumab in the setting of CMV infection has never been described. We present an unusual case of a 38-year-old female with a past medical history of seronegative rheumatoid arthritis (SnRA) who developed SLE associated with the use of adalimumab and CMV infection...
February 2023: Curēus
https://read.qxmd.com/read/35085210/drugs-for-rheumatoid-arthritis
#3
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
November 15, 2021: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/34550962/ozanimod-zeposia-for-ulcerative-colitis
#4
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
September 20, 2021: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/29282389/listeria-monocytogenes-brain-abscess-in-crohn-s-disease-treated-with-adalimumab
#5
Amporn Atsawarungruangkit, Fernando Dominguez, Gustavo Borda, Nikolaos Mavrogiorgos
Listeria monocytogenes is a gram-positive bacterium that causes listeriosis. Brain abscess is a very uncommon manifestation of listeriosis and has not been reported to be associated with adalimumab (humira), one of the approved medications for treating Crohn's disease. A 45-year-old female with Crohn's disease presented with sudden onset of fever, headache, nausea, vomiting, and altered mental status for 1 day. She was on prednisone and 6-mercaptopurine. She had started taking adalimumab 17 days prior to admission...
September 2017: Case Reports in Gastroenterology
https://read.qxmd.com/read/26828145/fdg-pet-ct-evidence-of-effective-treatment-of-cardiac-sarcoidosis-with-adalimumab
#6
JOURNAL ARTICLE
Christina T Miller, Nadera J Sweiss, Yang Lu
A 53-year-old man with mediastinal lymph node biopsy and cardiac MRI-proven cardiac sarcoidosis (CS) received treatment with pacemaker and steroids. FDG PET/CT showed active CS despite treatment with prednisone and methotrexate. Addition of weekly adalimumab (Humira) injections was introduced for 3 months. Follow-up FDG PET/CT showed complete resolution of CS as well as improvement of other sarcoid lesions in the thoracic lymph nodes.
May 2016: Clinical Nuclear Medicine
https://read.qxmd.com/read/23817208/autoimmune-inner-ear-disease-a-retrospective-review-of-forty-seven-patients
#7
JOURNAL ARTICLE
Akihiro J Matsuoka, Jeffrey P Harris
The purpose of this retrospective study was to characterize and further define autoimmune inner ear disease (AIED) using the Harris AIED classification. A retrospective review was conducted at two tertiary medical centers for 47 patients who were diagnosed with AIED. The overall patient response rate to oral prednisone treatment was 69.7%. The sensitivity of the test for a serum antibody against heat-shock protein 70 (HSP70) was 54.5% and the specificity was 42.9%. Therefore, the clinical utility of the HSP70 antibody test appeared to be limited with respect to the diagnosis of AIED...
2013: Audiology & Neuro-otology
https://read.qxmd.com/read/19830230/systemic-sarcoidosis-with-bone-marrow-involvement-responding-to-therapy-with-adalimumab-a-case-report
#8
JOURNAL ARTICLE
Supen R Patel
INTRODUCTION: Sarcoidosis is an inflammatory disorder characterized by the presence of non-caseating granulomas in affected organs. The presence of CD4-positive T lymphocytes and macrophages in affected organs suggests an ongoing immune response. Systemic corticosteroids remain the mainstay of treatment, but therapy is often limited by adverse effects. This is the first report of the use of adalimumab (HUMIRA((R)), Abbott Laboratories, North Chicago, IL, USA), an anti-tumor necrosis factor monoclonal antibody, in a patient with systemic sarcoidosis with bone marrow involvement...
2009: Journal of Medical Case Reports
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.